Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Polypharmacy, drug-drug interactions, anticholinergic burden and cognitive outcomes: a snapshot from a community-dwelling sample of older men and women in northern Italy ; volume:21 ; number:1 ; day:29 ; month:3 ; year:2024 ; pages:1-14 ; date:12.2024
European journal of ageing ; 21, Heft 1 (29.3.2024), 1-14, 12.2024
- Creator
-
Perdixi, Elena
Cotta Ramusino, Matteo
Costa, Alfredo
Bernini, Sara
Conti, Silvia
Jesuthasan, Nithiya
Severgnini, Marco
Prinelli, Federica
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10433-024-00806-0
- URN
-
urn:nbn:de:101:1-2406170934365.436602166823
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Perdixi, Elena
- Cotta Ramusino, Matteo
- Costa, Alfredo
- Bernini, Sara
- Conti, Silvia
- Jesuthasan, Nithiya
- Severgnini, Marco
- Prinelli, Federica
- SpringerLink (Online service)
Other Objects (12)
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
Targeting continuity of care and polypharmacy to reduce drug–drug interaction
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions